Clindamycin hydrochloride and Chronic obstructive lung disease - from FDA reports


Summary

Chronic obstructive lung disease is found among people who take Clindamycin Hydrochloride, especially for people who are male, 40-49 old , have been taking the drug for 6 - 12 months, also take medication Zometa, and have Metastases to bone . We study 921 people who have side effects while taking Clindamycin hydrochloride from FDA. Among them, 7 have Chronic obstructive lung disease. Find out below who they are, when they have Chronic obstructive lung disease and more.

What to expect?

If you take Clindamycin hydrochloride and have Chronic obstructive lung disease, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Clindamycin hydrochloride and have Chronic obstructive lung disease

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Clindamycin Hydrochloride

Clindamycin hydrochloride has active ingredients of clindamycin hydrochloride. It is often used in infection. (latest outcomes from Clindamycin hydrochloride 1,377 users)

Chronic Obstructive Lung Disease

Chronic obstructive lung disease (long lasting disease of lung with functional changes) has been reported by people with chronic obstructive pulmonary disease, osteoporosis, high blood pressure, rheumatoid arthritis, pain (latest reports from 99,895 Chronic obstructive lung disease patients).

On Feb, 06, 2017

921 people reported to have side effects when taking Clindamycin Hydrochloride.
Among them, 7 people (0.76%) have Chronic Obstructive Lung Disease


Number of reports submitted per year:

Could Clindamycin hydrochloride cause Chronic obstructive lung disease?

Time on Clindamycin Hydrochloride when people have Chronic Obstructive Lung Disease *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Chronic Obstructive Lung Disease when taking Clindamycin Hydrochloride *:

  • female: 42.86 %
  • male: 57.14 %

Age of people who have Chronic Obstructive Lung Disease when taking Clindamycin Hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 14.29 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 57.14 %
  • 50-59: 0.0 %
  • 60+: 28.57 %

Top conditions involved for these people *:

  • Restless Leg Syndrome (2 people, 28.57%)
  • Multiple Myeloma (2 people, 28.57%)
  • Metastases To Bone (2 people, 28.57%)
  • Immunodeficiency Disorders (1 person, 14.29%)
  • Atrial Fibrillation/flutter (1 person, 14.29%)

Top co-used drugs for these people *:

  • Zometa (5 people, 71.43%)
  • Elavil (4 people, 57.14%)
  • Vistaril (3 people, 42.86%)
  • Prednisone (3 people, 42.86%)
  • Oxycodone (3 people, 42.86%)

Top other side effects for these people *:

  • Fatigue (6 people, 85.71%)
  • Pain (5 people, 71.43%)
  • Osteoarthritis (5 people, 71.43%)
  • Intervertebral Disc Protrusion (5 people, 71.43%)
  • Headache (5 people, 71.43%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Chronic obstructive lung disease when taking Clindamycin hydrochloride?

Browse all side effects of Clindamycin hydrochloride

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Chronic obstructive lung disease

Chronic obstructive lung disease

Could your condition cause Chronic obstructive lung disease

Chronic obstructive lung disease

Related studies

Can you answer these questions?

More questions for: Clindamycin hydrochloride, Chronic obstructive lung disease

You may be interested in these reviews

More reviews for: Clindamycin hydrochloride, Chronic obstructive lung disease